B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patientsArticle Published on 2022-11-012022-11-15 Journal: European journal of neurology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI 95% confidence interval Affect anti-CD20 anti-CD20 treatment antibody Antibody Response Antibody titers B cell B cells B-cell B-cell depletion Blood booster cellular response Cohort correlated detectable develop Efficacy Guidance humoral identify IgG^{+} interleukin-13 Logistic regression median memory multiple sclerosis naïve no correlation Odds ratio Patient patients predict predictor Probability recent rituximab S1 domain SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine Seroconversion T-cell Response treated Treatment turn vaccination vaccine responses [DOI] 10.1111/ene.15492 PMC 바로가기
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosisArticle Published on 2022-11-012022-11-16 Journal: Journal of hepatology [Category] SARS, 변종, [키워드] 95% CI appear B.1.1.529 B.1.617.2 BNT BNT162b2 BNT162b2 mRNA booster booster dose chronic liver disease cirrhosis compensated Control control group COVD-19 COVID-19 COVID-19 in patient COVID-19 vaccines COVID-19-related death Critical dose doses General population greater hepatic decompensation hyporesponsiveness immune dysregulation liver magnitude moderate Moderate COVID-19 Moderna mRNA-1273 vaccine mRNA vaccine mRNA-1273 outcome overcome participant Patient Pfizer predominant receipt reduction in retrospective cohort study risk of infection Support symptomatic the vaccine Vaccine Vaccines variants veteran with COVID-19 [DOI] 10.1016/j.jhep.2022.07.036 PMC 바로가기
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceArticle Published on 2022-11-012022-11-15 Journal: Journal of the European Academy of Dermatology and [Category] COVID19(2023년), SARS, 진단, [키워드] Adverse reaction booster Cutaneous multicentre SARS-CoV-2 vaccine [DOI] 10.1111/jdv.18386 PMC 바로가기
Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemicArticle Published on 2022-11-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome analyses analyzed booster build change concern conducted confidence coronavirus coronavirus disease COVID-19 COVID-19 vaccination cross-sectional declined Effectiveness Efficacy Epidemic Factor immunization indicate investigated Modification Odds ratio pandemic propensity score matching PSM SARS-CoV-2 SARS-CoV-2 vaccine significant increase the SARS-CoV-2 the vaccine Treatment vaccination vaccination intention Vaccine Vaccine acceptance Vaccine confidence vaccine willingness variant were measured [DOI] 10.1002/jmv.28004 PMC 바로가기
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infectionArticle Published on 2022-11-012022-11-15 Journal: Journal of Clinical Virology [Category] SARS, 변종, 진단, 치료기술, [키워드] antibody Antibody neutralization Antibody titre B.1.1.529 BNT162b2 booster Breakthrough infection convalescent CoronaVac COVID-19 detectable dose elicited geometric GMT Immune escape individual Infection less natural infection neutralization neutralizing antibody Neutralizing antibody response of BNT162b2 omicron Omicron, Neutralization plaque reduction neutralization PRNT reduction relative SARS-CoV-2 susceptible Transmissibility vaccinated individual vaccination Vaccine Vaccines virus viruses VoC wild- type WT virus [DOI] 10.1016/j.jcv.2022.105273 PMC 바로가기
SARS-CoV-2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to AskArticle Published on 2022-11-012022-11-15 Journal: Yonsei medical journal [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome booster coronavirus COVID-19 disease severity Diseases domain effective Effectiveness Epidemiology evade genetics immune response increase in Infection less monoclonal antibody morbidity and mortality mutated Mutation omicron Omicron variant pandemic Protein reported SARS-CoV-2 Spread the Spike Transmissibility Treatment Vaccine variant variant of concern variants virus [DOI] 10.3349/ymj.2022.0383 PMC 바로가기
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic reviewArticle Published on 2022-11-012022-11-15 Journal: British Journal of Cancer [Category] COVID19(2023년), SARS, 진단, [키워드] access acute respiratory syndrome Affect Antibody Response anticancer association B-cell benefit booster booster dose booster vaccination Booster vaccine Cancer Coronavirus-2 depleting dose doses Efficacy evaluated Evidence haematological malignancies immunological responses include induce Infection malignancies morbidity and mortality organ Patient patients Patients with cancer receive recent risk SARS-CoV-2 SARS-CoV-2 vaccination Seroconversion significantly increased solid cancer systematic narrative review systematic review therapy vaccination [DOI] 10.1038/s41416-022-01951-y PMC 바로가기
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] SARS, 진단, [키워드] adjusted age All participant anti-SARS-CoV-2 anti-TNF antibody Antibody binding antibody concentration Antibody concentrations approved available data boost booster case-control study combination therapy Concentration control group COVID-19 COVID-19 vaccine Diagnosis disease dose Evidence first dose geometric mean geometric mean ratio group groups had no healthy control healthy individuals heterologous vaccine homologous IBD Immunosuppressed immunosuppressed patient immunosuppressive Immunosuppressive treatment Infection Inflammatory bowel disease jak inhibitors multicentre multivariable nine no significant difference Older Older age participant Patient patients treated Pfizer Primary outcome receiving Receptor binding domain recipient recruited reduced regimen response S1 RBD SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccination significantly significantly lower Support T-cell Response T-cell responses the healthy therapy Tofacitinib Treatment ulcerative colitis Vaccine vaccine dose vaccine doses vaccine-induced antibody response VIP were measured [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccineArticle Published on 2022-11-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] analyzed antibody Antibody titer B cell booster booster dose caused Cell Cluster Concentration conducted COVID-19 COVID-19 vaccine CyTOF Cytometry declined decrease distribution Efficacy ENhance healthy highlight humoral Immune cell immune response Immunity immunization immunoassay immunological profile inactivated individual injection Injections lack maintain marker multicenter neutralizing antibody not significantly different participant prevalence of COVID-19 proportion protective effect recall receiving recruited reduced SARS-CoV-2 second dose serum antibody shown significantly significantly increased Still subject surface marker sVNT the antibody response the vaccine vaccination Vaccine vaccine doses vaccine injection Viral variants virus neutralization test [DOI] 10.1002/jmv.27983 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, FloridaArticle Published on 2022-10-292022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] acute infection acute respiratory syndrome association average booster caused Characteristics conducted Contact Contact tracing coronavirus coronavirus 2 Delta delta variant Epidemic evaluate exhibited Florida genomes Immunity Infection interquartile range Lineage majority occurred Patient Phylogenetic Phylogenetic analysis public health question raising regression analysis respiratory SARS-CoV-2 SARS-CoV2 sequence sequenced Spread threshold through contact Transmissibility Transmission vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose Viral RNA viral RNA quantification were used [DOI] 10.1093/cid/ciac197 PMC 바로가기